-+ 0.00%
-+ 0.00%
-+ 0.00%

ASSEMBLY BIOSCIENCES - GILEAD RETAINS SOLE RIGHT FOR CLINICAL DEVELOPMENT AND COMMERCIALIZATION OF HSV HPI PROGRAM

Reuters·09/08/2026 20:00:00

Please log in to view news